Lacosamide 51991-0349
Product NDC
51991-0349- Manufacturer
- Breckenridge Pharmaceutical, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- March 18, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA204921
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 100 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(2)
500 TABLET, FILM COATED in 1 BOTTLE (51991-349-05)
60 TABLET, FILM COATED in 1 BOTTLE (51991-349-06)